DexCom (DXCM) News Today $80.48 -1.35 (-1.65%) As of 01:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is DexCom Down Today?DexCom, Inc. (NASDAQ:DXCM) shares have decreased today following a mix of company updates and insider activity. Unveiled its “Dexcom State of Type 2 Report” at ADA 2025, showcasing leadership in continuous glucose monitoring and reinforcing its market position. Truist Financial initiated coverage on DXCM, bringing fresh analyst focus to the stock. An “Expert Outlook” piece summarized views from eight analysts, reflecting a range of forecasts for DXCM’s prospects. A Globe and Mail article questioned whether DXCM is underperforming the broader health care sector, prompting comparative performance scrutiny. Director Nicholas Augustinos sold a combined 6,290 shares in mid-June (at average prices of $81.69 and $82.80), cutting his stake by about 16.5%—a potential signal of insider caution. Issued a Class I recall on one of its CGM receivers, creating short-term product liability and regulatory concerns. Posted 1h agoAI Generated. May Contain Errors. DXCM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025June 18 at 9:07 AM | businesswire.comDexCom, Inc. (NASDAQ:DXCM) Director Sells $213,864.42 in StockJune 18 at 5:53 AM | insidertrades.comSagespring Wealth Partners LLC Acquires 5,172 Shares of DexCom, Inc. (NASDAQ:DXCM)Sagespring Wealth Partners LLC boosted its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 96.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,552 shares of the medical device company's stock after acquiring an additional 5,172 sJune 18 at 4:22 AM | marketbeat.comDexCom Stock: Is DXCM Underperforming the Health Care Sector?June 17 at 11:59 PM | theglobeandmail.comInsider Selling: DexCom, Inc. (NASDAQ:DXCM) Director Sells 2,618 Shares of StockDexCom, Inc. (NASDAQ:DXCM - Get Free Report) Director Nicholas Augustinos sold 2,618 shares of the stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $81.69, for a total value of $213,864.42. Following the completion of the transaction, the director now directly owns 37,083 shares of the company's stock, valued at approximately $3,029,310.27. The trade was a 6.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.June 17 at 8:56 PM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Director Nicholas Augustinos Sells 3,672 SharesDexCom, Inc. (NASDAQ:DXCM - Get Free Report) Director Nicholas Augustinos sold 3,672 shares of DexCom stock in a transaction on Monday, June 16th. The stock was sold at an average price of $82.80, for a total value of $304,041.60. Following the transaction, the director now directly owns 33,411 shares of the company's stock, valued at $2,766,430.80. This trade represents a 9.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.June 17 at 8:41 PM | marketbeat.comExpert Outlook: DexCom Through The Eyes Of 8 AnalystsJune 17 at 8:58 AM | benzinga.comPKO Investment Management Joint Stock Co Grows Stock Position in DexCom, Inc. (NASDAQ:DXCM)PKO Investment Management Joint Stock Co boosted its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 89.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 91,000 shares of the medical device company's sJune 17 at 6:55 AM | marketbeat.comChicago Capital LLC Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM)Chicago Capital LLC raised its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 75.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 885,532 shares of the medical device company's stock after acquiring an additionJune 17 at 5:56 AM | marketbeat.comGrimes & Company Inc. Buys Shares of 134,935 DexCom, Inc. (NASDAQ:DXCM)Grimes & Company Inc. bought a new stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 134,935 shares of the medical device company's stock, valued at approximately $9,21June 17 at 4:52 AM | marketbeat.comMn Services Vermogensbeheer B.V. Sells 10,800 Shares of DexCom, Inc. (NASDAQ:DXCM)Mn Services Vermogensbeheer B.V. cut its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 7.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 139,800 shares of the medical device company's stock after selling 10,800 shares during theJune 17 at 4:00 AM | marketbeat.comSG Americas Securities LLC Has $1.17 Million Position in DexCom, Inc. (NASDAQ:DXCM)SG Americas Securities LLC raised its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 193.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,097 shares of the medical device company's stock afteJune 17 at 3:27 AM | marketbeat.comDexCom (NASDAQ:DXCM) Coverage Initiated at Truist FinancialJune 17 at 2:41 AM | americanbankingnews.comTop Analyst Assigns Buy Rating to ‘Leading Innovator’ DexCom’s Stock (DXCM)June 16 at 11:31 AM | tipranks.comTruist starts on diabetes device makers, sees glucose monitor, insulin pump growthJune 16 at 10:21 AM | investing.comTruist Financial Initiates Coverage on DexCom (NASDAQ:DXCM)Truist Financial initiated coverage on DexCom in a research report on Monday. They set a "buy" rating and a $102.00 price objective for the company.June 16 at 8:37 AM | marketbeat.comDexCom (DXCM) Receives Buy Rating Amid Promising Market Prospects | DXCM Stock NewsJune 16 at 7:14 AM | gurufocus.comDexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Bank Pictet & Cie Europe AGBank Pictet & Cie Europe AG boosted its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 5.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 117,575 shares of the medical device company's stock after acquiring anJune 16 at 5:31 AM | marketbeat.com4,294 Shares in DexCom, Inc. (NASDAQ:DXCM) Bought by Azzad Asset Management Inc. ADVAzzad Asset Management Inc. ADV purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 4,294 shares of the medical device company's stock, valued aJune 16 at 4:15 AM | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Factory Mutual Insurance Co.Factory Mutual Insurance Co. raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 8.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 521,630 shares of the medical device company's stockJune 15 at 7:51 AM | marketbeat.comDexCom's SWOT analysis: CGM leader's stock poised for growth amid challengesJune 13, 2025 | investing.comTobam Sells 10,493 Shares of DexCom, Inc. (NASDAQ:DXCM)Tobam lowered its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 18.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 46,241 shares of the medical device company's stock after selling 10,493 shares during the quartJune 13, 2025 | marketbeat.comAssenagon Asset Management S.A. Raises Position in DexCom, Inc. (NASDAQ:DXCM)Assenagon Asset Management S.A. lifted its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 0.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 650,679 shares of the medical device company's stocJune 13, 2025 | marketbeat.comCompagnie Lombard Odier SCmA Sells 4,790 Shares of DexCom, Inc. (NASDAQ:DXCM)Compagnie Lombard Odier SCmA decreased its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 3.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 130,020 shares of the medical device coJune 12, 2025 | marketbeat.comPark Avenue Securities LLC Increases Stake in DexCom, Inc. (NASDAQ:DXCM)Park Avenue Securities LLC raised its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 35.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 18,086 shares of the medical device company's stock after purchasing an additional 4,739 shares during the quarteJune 12, 2025 | marketbeat.comWedmont Private Capital Buys New Shares in DexCom, Inc. (NASDAQ:DXCM)Wedmont Private Capital bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,231 shares of the medical device company's stock, valued at approximJune 12, 2025 | marketbeat.comMerit Financial Group LLC Has $405,000 Position in DexCom, Inc. (NASDAQ:DXCM)Merit Financial Group LLC raised its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 102.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,933 shares of the medical device company's stoJune 11, 2025 | marketbeat.comDexCom Inc (DXCM) Under Investigation for Potential Securities Law Violations | DXCM stock newsJune 10, 2025 | gurufocus.comJohnson Fistel Continues Investigation on Behalf of DexCom, Inc. ShareholdersJune 10, 2025 | businesswire.comDexCom, Inc. (NASDAQ:DXCM) Receives $98.32 Consensus Price Target from AnalystsJune 10, 2025 | americanbankingnews.comStocks With Rising Relative Strength: DexComJune 9, 2025 | msn.comDexCom (NASDAQ:DXCM) Stock Rating Upgraded by Wall Street ZenJune 9, 2025 | americanbankingnews.comCongress Asset Management Co. Trims Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Congress Asset Management Co. decreased its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 14.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,159,747 shares of the medical dJune 7, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of DexCom, Inc. (NASDAQ:DXCM - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twenty-one brokerages that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, fourteen have given aJune 7, 2025 | marketbeat.comWall Street Zen Upgrades DexCom (NASDAQ:DXCM) to "Buy"Wall Street Zen upgraded shares of DexCom from a "hold" rating to a "buy" rating in a research report on Friday.June 7, 2025 | marketbeat.comPortside Wealth Group LLC Makes New Investment in DexCom, Inc. (NASDAQ:DXCM)Portside Wealth Group LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,187 shares of the medical device company's stocJune 6, 2025 | marketbeat.comJohnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. ShareholdersJune 5, 2025 | globenewswire.comDexCom, Inc. (NASDAQ:DXCM) Shares Bought by Patten & Patten Inc. TNPatten & Patten Inc. TN boosted its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 77,958 shares of the medical device company's stock aftJune 5, 2025 | marketbeat.comJefferies’ high conviction US stocks for the summer: Nvidia among top picksJune 4, 2025 | msn.comSendero Wealth Management LLC Makes New Investment in DexCom, Inc. (NASDAQ:DXCM)Sendero Wealth Management LLC bought a new stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 10,619 shares of the medical deviJune 4, 2025 | marketbeat.comHarbor Investment Advisory LLC Boosts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Harbor Investment Advisory LLC boosted its stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 754.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,964 shares of the medical device company's stock after acquiring an additionJune 4, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Position Increased by GAMMA Investing LLCGAMMA Investing LLC boosted its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 5,951.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 499,746 shares of the medical device company's stock after buying an additional 491,488 sharesJune 4, 2025 | marketbeat.comDexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Czech National BankCzech National Bank raised its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 6.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 89,737 shares of the medical device company's stock after purchasing an additional 5,048 shares during the period. Czech NatiJune 3, 2025 | marketbeat.comRhumbline Advisers Purchases 33,574 Shares of DexCom, Inc. (NASDAQ:DXCM)Rhumbline Advisers boosted its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 4.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 809,803 shares of the medical device company's stJune 3, 2025 | marketbeat.comGradient Investments LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)Gradient Investments LLC raised its position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 10.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 281,325 shares of the medical device company's stock after buying an additional 26,782June 2, 2025 | marketbeat.comFulcrum Capital LLC Takes Position in DexCom, Inc. (NASDAQ:DXCM)Fulcrum Capital LLC acquired a new stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 34,072 shares of the medical device company's stock, valued at approximately $2,327,000. SeveJune 1, 2025 | marketbeat.comCentral Pacific Bank Trust Division Makes New Investment in DexCom, Inc. (NASDAQ:DXCM)Central Pacific Bank Trust Division acquired a new position in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 8,646 shares of the medical device company's stock, vaJune 1, 2025 | marketbeat.comDexCom (NASDAQ:DXCM) Shares Gap Up - Here's What HappenedDexCom (NASDAQ:DXCM) Shares Gap Up - Here's What HappenedMay 31, 2025 | marketbeat.comDexCom (NASDAQ:DXCM) Now Covered by The Goldman Sachs GroupThe Goldman Sachs Group began coverage on shares of DexCom in a report on Friday. They set a "buy" rating and a $104.00 target price on the stock.May 31, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of DexCom (DXCM) with Buy RecommendationMay 31, 2025 | msn.com Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Email Address DXCM Media Mentions By Week DXCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXCM News Sentiment▼1.030.56▲Average Medical News Sentiment DXCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXCM Articles This Week▼2826▲DXCM Articles Average Week Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Medtronic News Today Becton, Dickinson and Company News Today Edwards Lifesciences News Today IDEXX Laboratories News Today ResMed News Today STERIS News Today Insulet News Today Baxter International News Today Hologic News Today Masimo News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DXCM) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe stealth altcoin the financial world is underestimatingWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s End Game Is Going Live -- And It Could Make You a FortuneThe media and the so-called experts have laughed at Elon Musk his entire career. CBS called PayPal “one of ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | SponsoredThe Dollar Reset Nobody’s Talking AboutCould this man take down the financial system? In March, the Senate granted sweeping powers to a Harvard ec...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
